Sponsor overview

Case Comprehensive Cancer Center

Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.

Back to report

Summary

Signal counts

Assets tracked: 1

Watchlist assets: 1

Registry stop assets: 1

Evidence links

Public sources

https://clinicaltrials.gov/study/NCT00003928 | https://clinicaltrials.gov/study/NCT02705612 | https://clinicaltrials.gov/study/NCT01910844 | https://clinicaltrials.gov/study/NCT04383743 | https://clinicaltrials.gov/study/NCT05640791 | https://clinicaltrials.gov/study/NCT01557959 | https://clinicaltrials.gov/study/NCT02734537

Assets

Linked programs

cisplatin: Registry Stop Signal (5/5)